
Intuitive Surgical, Inc.
0.0 %
29.31 %
Yet to be announced
Company Overview
Intuitive Surgical, Inc. is a global leader in robotic-assisted, minimally invasive surgery. The company develops, manufactures, and markets the da Vinci Surgical System, an advanced robotic-assisted surgical platform. The system enables surgeons to perform minimally invasive surgery through small incisions using robotic technology, providing enhanced visualization and precise control.
The company generates revenue primarily through the sale of its da Vinci Surgical Systems, related instruments and accessories, and service contracts. They also provide training and support to healthcare providers using their systems.
Revenue Sources
PassBased on review of the company's SEC filings and financial statements, Intuitive Surgical's revenue comes primarily from the sale and service of medical devices and equipment, specifically their da Vinci Surgical Systems and related products and services. These are all halal sources of revenue as they provide legitimate medical benefits and involve the exchange of actual products and services.
Reliance on Interest
Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
---|---|---|---|---|---|---|
March 31, 2025 | $2.25b | $1.68b | - | - | 0.00% | 0.00% |
Dec. 31, 2024 | $2.41b | $1.68b | - | - | 0.00% | 0.00% |
Sept. 30, 2024 | $2.04b | $1.46b | - | - | 0.00% | 0.00% |
June 30, 2024 | $2.01b | $1.44b | - | - | 0.00% | 0.00% |
Analysis of the company's financial statements for the past four quarters shows zero interest income and zero interest expense. The company operates with minimal to no debt and does not derive income from interest-based activities.
Operational Ethics
PassBased on review of the company's public disclosures and operations, there is no evidence of significant ongoing associations with entities involved in human rights violations. The company's primary markets are in North America, Europe, and Asia, with operations conducted in compliance with international healthcare regulations.
Comments